Wikidata

(Q38075218)

English

Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer

scientific article published on 16 January 2013

In more languages

Statements

title
Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23332287
retrieved
28 August 2017
author name string
Shirish M Gadgeel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
23332287
retrieved
28 August 2017
Antoinette Wozniak
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
23332287
retrieved
28 August 2017
publication date
16 January 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
23332287
retrieved
28 August 2017
page(s)
322-332
1 reference
stated in
Europe PubMed Central
PubMed ID
23332287
retrieved
28 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38075218&oldid=1966791332"